logo-BL.png
  • banner.png
Services

Premium Service Levels

Our service offering is designed to help you deliver safe and effective products to market and maintain compliance with the regulatory authorities.  Within Pharma Services, we provide analytical development, quality control testing, stability storage and testing, and complaint method transfers to support your products throughout the drug development pathway to commercialisation.

Within Nicotine Services, we deliver routine quality control testing as well as full project management to help you achieve your compliance goals to the following regulations: EU TPD, EU Medicinal Product and PMTA. By aligning ourselves with your goals, our collaborative approach provides the foundation for successful partnerships.

Techniques

Scientific Ingenuity

Our clients rely on our scientific expertise and thorough recommendations to support the lifespan of their products.  Our team of qualified scientists keep up to date with the latest techniques and technology available in a wide variety of industries.

Quality

Continuous High Quality

We are committed to the continuous delivery of high quality services that meet the expectations of our clients.  From the vision and core values of our organisation to the operational processes that we perform, we continually improve and pursue excellence.  We also undertake the responsibility for maintaining compliance and keep up-to-date with the latest regulations. Read more about our commitment to quality. 

Most Recent Blog Articles

E-cigarette Safety. The Evidence is Growing

E-cigarette Safety. The Evidence is Growing

Electronic cigarettes are battery powered electronic devices that enable delivery of nicotine to a user without the combustion...

Vape and the FDA Event Coverage

Vape and the FDA Event Coverage

Last week we attended the Vape and the FDA event hosted by the Vapor Technology Association (VTA) in Washington DC.  It was...

What is the Impact of Brexit for Pharma Companies?

What is the Impact of Brexit for Pharma Companies?

Next year, Britain will leave the EU, but what does that mean for Pharmaceutical companies that outsource their EU batch...